Your browser doesn't support javascript.
loading
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.
Nichols, Brandt A; Oswald, Nathaniel W; McMillan, Elizabeth A; McGlynn, Kathleen; Yan, Jingsheng; Kim, Min S; Saha, Janapriya; Mallipeddi, Prema L; LaDuke, Sydnie A; Villalobos, Pamela A; Rodriguez-Canales, Jaime; Wistuba, Ignacio I; Posner, Bruce A; Davis, Anthony J; Minna, John D; MacMillan, John B; Whitehurst, Angelique W.
Afiliación
  • Nichols BA; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Oswald NW; Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas.
  • McMillan EA; Department of Cell Biology, UT Southwestern Medical Center, Dallas, Texas.
  • McGlynn K; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Yan J; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas.
  • Kim MS; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas.
  • Saha J; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
  • Mallipeddi PL; Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas.
  • LaDuke SA; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Villalobos PA; Department of Translational Molecular Pathology, M.D. Anderson Cancer Center, Houston, Texas.
  • Rodriguez-Canales J; Department of Translational Molecular Pathology, M.D. Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Translational Molecular Pathology, M.D. Anderson Cancer Center, Houston, Texas.
  • Posner BA; Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas.
  • Davis AJ; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
  • Minna JD; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • MacMillan JB; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.
  • Whitehurst AW; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California.
Cancer Res ; 78(21): 6196-6208, 2018 11 01.
Article en En | MEDLINE | ID: mdl-30185546
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Proteínas de Ciclo Celular / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Proteínas de Ciclo Celular / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos